Der sås ingen relevante forskelle mellem Filgrastim ratiopharm og referenceproduktet, hvad angår varighed af svær neutropeni og incidens af febril neutropeni.
There were no relevant differences between Filgrastim ratiopharm and the reference product with regard to duration of severe neutropenia and incidence of febrile neutropenia.